Novo Nordisk said on Monday it was offering its diabetes drug Ozempic for $499 per month to eligible cash-paying patients ...

Please watch the video at Investors.com - Novo Nordisk Is Losing Its Lead To Eli Lilly In The Obesity Drug War. Here's What ...

Cash-paying type 2 diabetes patients in the United States can now access Novo Nordisk's Ozempic for $499 per month through ...

Novo Nordisk’s stock popped Monday after it announced a cash discount for uninsured Ozempic users and gained FDA approval for Wegovy to be used for liver treatment. The pharma giant's stock rose more ...

The maker of Ozempic is halving the price of its weight-loss jabs in the US after Donald Trump demanded cheaper drugs for ...

Novo Nordisk, the manufacturer of Ozempic, is facing a lawsuit over alleged vision problems caused by the drug ...

Nordic stocks rose Monday, with the OMX Nordic 40 Index rising 1.1%. Vestas Wind Systems A/S was the biggest leader among large stocks during the session, surging 15.1%, and Novo Nordisk A/S increased ...

I would like to receive updates and special offers from Dow Jones and affiliates. I can unsubscribe at any time.